Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 to 80~2. Skin and soft tissue infections (SSTIs), in the form of an abscess, which will require incision and drainage.~3. Patient able to provide an informed consent.~4. Patient volunteers to participate.~Exclusion Criteria:~1. Wound was caused by human or animal bite.~2. Wound is a blunt crush injury or has tendon, bone, or joint involvement.~3. Diabetic foot infection.~4. Anticipated incision size less than 5mm.~5. Abscess extends to the muscle layer.~6. Admission to hospital for any reason, including IV antibiotics.~7. Clinical signs of systemic infection on initial patient encounter.~8. Prior history of allergy or hypersensitivity to CHG.~9. Neutropenic (known ANC\<500/mm3), HIV (known CD4\<50), or other severely immunocompromised state (e.g., receiving chemotherapy).~10. Patient is diagnosed with systemic lupus erythematosus or other immunological disease.~11. Currently in police custody.~12. Patient withdraws from participation.~13. Patient unable or unwilling to give informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Standard of Care (SoC) (Type: ACTIVE_COMPARATOR): For subjects randomized to the control group, the preferred irrigation solution was chosen by the site's emergency department physician(s).
- Irrisept (Type: ACTIVE_COMPARATOR): For subjects randomized to the investigational group, Irrisept was used.

Based on this trial design, predict the completion outcome and termination type (if applicable).